MIR1912

Q-omics provides the consensus-scored MIR1912 profile across patient tissues and cancer cell-line models. MIR1912 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, MIR1912 RNA expression shows 3,855 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight STAD as cancer lineages where MIR1912 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes MIR1912 survival associations across molecular data types. MIR1912 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MIR1912 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	STAD (45)	view →

This table ranks reproducible MIR1912 RNA expression–survival associations across cancer types. High MIR1912 expression shows unfavorable associations in STAD. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .019). Together, the overview and detailed table identify STAD as the clearest survival context for MIR1912 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.215	0.660	.019	45	view →

Pink = unfavorable, green = favorable. all 1 lineages →

MIR1912-STAD (OS)

Explore this curve interactively →